CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...
Phase 2
Nashville, Tennessee, United States and 8 other locations
This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...
Phase 2
Nashville, Tennessee, United States and 10 other locations
This research study is a way of gaining new knowledge about the combination of Taselisib with other drugs in the treatment of metastatic breast...
Phase 1
Nashville, Tennessee, United States and 2 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:A combi...
Phase 2
Nashville, Tennessee, United States and 25 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Nashville, Tennessee, United States and 9 other locations
This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...
Phase 2
Nashville, Tennessee, United States and 12 other locations
This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...
Phase 2
Nashville, Tennessee, United States and 48 other locations
The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant
Phase 1
Nashville, Tennessee, United States and 4 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Nashville, Tennessee, United States and 10 other locations
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Nashville, Tennessee, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal